Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 115.28K CHF in the quarter ending June 30, 2024, a decrease of -81.76%. This brings the company's revenue in the last twelve months to 863.23K, down -59.82% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.

• Revenue (ttm): 863.23K CHF
• Revenue Growth: -59.82%
• P/S Ratio: n/a
• Revenue / Employee: 37,532 CHF
• Employees: 23
• Market Cap: 9.16M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.65M	202.11K	13.99%
Dec 31, 2022	1.44M	-1.71M	-54.18%
Dec 31, 2021	3.15M	-725.84K	-18.71%
Dec 31, 2020	3.88M	1.05M	36.89%
Dec 31, 2019	2.83M	-3.87M	-57.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.